BCYC - Bicycle Therapeutics GAAP EPS of -$1.26 revenue of $5.35M
2023-11-02 09:14:48 ET
More on Bicycle Therapeutics
- Bicycle Therapeutics: Pedaling Through Uncertainty
- Bicycle Therapeutics gains as FDA expedites path for bladder cancer therapy
- Seeking Alpha’s Quant Rating on Bicycle Therapeutics
- Historical earnings data for Bicycle Therapeutics
- Financial information for Bicycle Therapeutics
For further details see:
Bicycle Therapeutics GAAP EPS of -$1.26, revenue of $5.35M